SCHEMBL23749768

SCHEMBL23749768

CCOC(=O)/N=c1\scc(C(C)C)n1Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
POLB P06746 2/20 0.47
GAA P10253 2/20 0.47
TSHR P16473 5/20 0.46
MAPT P10636 4/20 0.46
GSK3B P49841 1/20 0.46
ATM Q13315 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MAPK1 P28482 1/20 0.44
RAB9A P51151 2/20 0.43
HSD17B10 Q99714 1/20 0.43
LMNA P02545 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TDP2 O95551 1/20 0.39
NSD2 O96028 1/20 0.39
PLCG1 P19174 1/20 0.39
PAX8 Q06710 1/20 0.39
KDM4E B2RXH2 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23727302 0.85 RAB9A (0.42) ALDH1A1POLBGAATSHRMAPT
SCHEMBL23727301 0.85 RAB9A (0.42) ALDH1A1POLBGAATSHRMAPT
SCHEMBL30130842 0.84 ALDH1A1 (0.47) ALDH1A1POLBGAATSHRMAPT
SCHEMBL25002133 0.83 ALDH1A1 (0.47) ALDH1A1POLBGAATSHRMAPT
SCHEMBL25002132 0.81 MAPT (0.48) ALDH1A1POLBGAATSHRMAPT
SCHEMBL23749770 0.81 ALDH1A1 (0.45) ALDH1A1POLBGAATSHRMAPT
SCHEMBL23749889 0.81 ALDH1A1 (0.44) ALDH1A1POLBGAATSHRMAPT
SCHEMBL23750082 0.74 ALDH1A1 (0.56) ALDH1A1POLBGAATSHRMAPT
SCHEMBL23749761 0.71 GSK3B (0.59) ALDH1A1POLBGAATSHRMAPT
SCHEMBL23727789 0.69 RAB9A (0.45) ALDH1A1POLBTSHRMAPTGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230137893-A1 PYRROLO[2,3-b]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS THE ROCKEFELLER UNIVERSITY (US) 2023-05-04 US disclosed
WO-2021158936-A1 PYRROLO [2,3-B]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS THE ROCKEFELLER UNIVERSITY (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230137893-A1 PYRROLO[2,3-b]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS LATS2, LATS1, YAP1 ALDH1A1 3775/4885POLB 1541/4885GAA 4035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.